Several key pathways (cell cycle, ECM-receptor interaction, p53 signaling, JAK-STAT signaling, focal adhesion, regulation of actin cytoskeleton, cancer and Toll-like receptor (TLR) signaling pathways) were significantly enriched in the high-risk group (Figures 6B–I). Here, TP53 is linked to cancer.